Blood Market 2023-2027 Along with 5-Year Historic (2017-2021) Industry Size & Comparison of 20 Vendors and 11 Countries

NEW YORK, Nov. 2, 2022 /PRNewswire/ -- The Blood Market share is expected to increase by USD 2195.69 million from 2022 to 2027, with an accelerated CAGR of 5.31% - according to a recent market study by Technavio. This report also offers a 5-year historic (2017-2021) data projection of market size, segment, and region. The Y-O-Y growth rate of the Blood Market is estimated at 4.13% as of 2023. Moreover, the market is fragmented. Our analysts have conducted an internal and external analysis of vendors to help companies understand the wider business environment as well as the strength and weaknesses of key market players. Our report also forecasts the Bargaining Power of Buyers & Suppliers and the Threat of New Entrants & Rivalry ranging between LOW-MODERATE during the forecast period.

Find Analysis of Price Sensitivity, Lifecycle, Customer Purchase Basket, Adoption Rates, and Purchase Criteria Prepared Exclusively by Technavio Research Analysts

• One of the core components of customer landscape is Price Sensitivity – an analysis of which will help companies refine marketing strategies to gain a competitive advantage.   
• Moreover, this report also provides impact of price sensitivity drivers (purchases are undifferentiated, purchase is a key cost to the buyer, and quality is not important) which are expected to range between LOW-HIGH from 2023-2027.
• Our report provides extensive information on the customer landscape of the Blood market, involving qualitative and quantitative intelligence. 

FOR A DETAILED OVERVIEW OF CUSTOMER LANDSCAPE, REQUEST SAMPLE PAGES

The Blood Market Report Also Offers Information on the Criticality of Inputs, R&D, Capex, Technology, Labor, and Brand of 20 Vendors Listed Below –

• Agena Bioscience Inc.
• AXO Science
• BAG Health Care GmbH
• Beckman Coulter Inc.
• Becton Dickinson & Co.
• Cardinal Health Inc.
• CSL Ltd.
• DIAGAST SAS
• F. Hoffmann La Roche Ltd.
• Grifols SA
• Haemonetics Corp.
• Immucor Inc.
• Medtronic Plc
• Nipro Medical Corp.
• Quest Diagnostics Inc.
• Rapid Labs Ltd.
• Terumo Corp.
• Merck KGaA
• Abbott Laboratories

DOWNLOAD SAMPLE REPORT FOR MORE ACCESS

Chart & Data Table on 5-Year Historic (2017-2021) Market Size, Comparison, and Y-O-Y Growth of Blood Industry Segment

• The market is segmented by Product (Whole Blood Collection and Processing, Blood Screening Products, Blood Typing Products, and Source Plasma Collection) and End-user (Hospitals, Ambulatory Surgical Centers (ASCs), and Others).
• By Product - The whole blood collection and processing segment shows a gradual increase in demand during 2023-2027.
• The growth of this segment is attributed to factors such as the growing demand for blood for various applications such as blood transfusions, surgical procedures, and the treatment of diseases.

INTERESTED TO PROCURE THE DATA?

DOWNLOAD SAMPLE REPORT

Rising Number of Hospitals and Blood Banks is Notably Driving the Blood Market Growth

The number of healthcare providers and their capability to provide specific services is increasing. The rising incidence of medical emergencies, chronic diseases, and disease outbreaks is supporting the expansion of patient care centers and hospitals. Donated blood needs a stand-by of blood bags to be stored at appropriate temperatures. In addition, improvements in healthcare coverage and changes in related laws have improved the accessibility and affordability of different types of medical treatment. The rise in the volume of blood and blood components available in storage facilities has led to a high demand for blood. Such factors are expected to drive market growth during the forecast period.

TO ACCESS WHAT ARE THE LATEST DRIVERS, TRENDS, AND CHALLENGES INFLUENCING THE GROWTH OF THIS MARKET? REQUEST SAMPLE REPORT

Chart & Data Table on Historic Market Size (2017-2021), Comparison and Y-O-Y Growth of 11 Countries of Blood Industry

• The market is segmented by Geography into North America (The US and Canada), Europe (The UK, Germany, France, and Rest of Europe), Asia (China and India), and Rest of World (Argentina, Australia, Brazil, and Rest of the world).
• North America is projected to contribute 40% of the market growth by 2027. The growth of this region is attributed to factors such as the growth in the number of different surgical procedures, the rising number of road accidents and sports injuries, the increasing number of blood donors, and the rising prevalence of different types of cancer. Growth in the end-user base will also drive the growth of the regional market. 
• The COVID-19 pandemic led to a rise in demand for blood in North America. As the pandemic spread across the region, the regional market was impacted in terms of supply of and demand for blood. In April 2020, the US FDA issued guidelines to address the urgent need for blood and blood components. This is expected to increase the number of blood donation drives, in turn, will drive the growth of the regional blood market during the forecast period. 

FOR MORE INSIGHTS ON THE MARKET SHARE OF VARIOUS REGIONS, VIEW PDF SAMPLE NOW!

Related Reports -

Venous Blood Collection Market by Application and Geography - Forecast and Analysis 2022-2026 – The market share is expected to increase by USD 868.11 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.73%. Furthermore, this report extensively covers market segmentation by application (vein blood gas sampling and intraoperative blood salvage) and geography (North America, Asia, Europe, and Rest of World (ROW)).  To get more exclusive research insights: VIEW SUMMARY OF THE REPORT FOR MORE 

Stem Cell Umbilical Cord Blood (UCB) Market by End-user and Geography - Forecast and Analysis 2022-2026 – The market share is expected to increase by USD 1.47 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 16.87%. The rising prevalence of several chronic disorders is one of the key factors driving the market growth. To get more exclusive research insights: VIEW SUMMARY OF THE REPORT FOR MORE

Browse Health Care Market Reports

Table of Contents

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Five Forces Analysis

• 4.1 Five forces summary 
• Exhibit 18: Five forces analysis - Comparison between 2022 and 2027

• 4.2 Bargaining power of buyers 
• Exhibit 19: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 4.3 Bargaining power of suppliers 
• Exhibit 20: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 4.4 Threat of new entrants 
• Exhibit 21: Threat of new entrants – Impact of key factors in 2022 and 2027

• 4.5 Threat of substitutes 
• Exhibit 22: Threat of substitutes – Impact of key factors in 2022 and 2027

• 4.6 Threat of rivalry 
• Exhibit 23: Threat of rivalry – Impact of key factors in 2022 and 2027

• 4.7 Market condition 
• Exhibit 24: Chart on Market condition - Five forces 2022 and 2027

5 Market Segmentation by Product

• 5.1 Market segments 
• Exhibit 25: Chart on Product - Market share 2022-2027 (%)
• Exhibit 26: Data Table on Product - Market share 2022-2027 (%)

• 5.2 Comparison by Product 
• Exhibit 27: Chart on Comparison by Product
• Exhibit 28: Data Table on Comparison by Product

• 5.3 Whole blood collection and processing - Market size and forecast 2022-2027 
• Exhibit 29: Chart on Whole blood collection and processing - Market size and forecast 2022-2027 ($ million)
• Exhibit 30: Data Table on Whole blood collection and processing - Market size and forecast 2022-2027 ($ million)
• Exhibit 31: Chart on Whole blood collection and processing - Year-over-year growth 2022-2027 (%)
• Exhibit 32: Data Table on Whole blood collection and processing - Year-over-year growth 2022-2027 (%)

• 5.4 Blood screening products - Market size and forecast 2022-2027 
• Exhibit 33: Chart on Blood screening products - Market size and forecast 2022-2027 ($ million)
• Exhibit 34: Data Table on Blood screening products - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Chart on Blood screening products - Year-over-year growth 2022-2027 (%)
• Exhibit 36: Data Table on Blood screening products - Year-over-year growth 2022-2027 (%)

• 5.5 Blood typing products - Market size and forecast 2022-2027 
• Exhibit 37: Chart on Blood typing products - Market size and forecast 2022-2027 ($ million)
• Exhibit 38: Data Table on Blood typing products - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Chart on Blood typing products - Year-over-year growth 2022-2027 (%)
• Exhibit 40: Data Table on Blood typing products - Year-over-year growth 2022-2027 (%)

• 5.6 Source plasma collection - Market size and forecast 2022-2027 
• Exhibit 41: Chart on Source plasma collection - Market size and forecast 2022-2027 ($ million)
• Exhibit 42: Data Table on Source plasma collection - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Chart on Source plasma collection - Year-over-year growth 2022-2027 (%)
• Exhibit 44: Data Table on Source plasma collection - Year-over-year growth 2022-2027 (%)

• 5.7 Market opportunity by Product 
• Exhibit 45: Market opportunity by Product ($ million)

6 Market Segmentation by End-user

• 6.1 Market segments 
• Exhibit 46: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 47: Data Table on End-user - Market share 2022-2027 (%)

• 6.2 Comparison by End-user 
• Exhibit 48: Chart on Comparison by End-user
• Exhibit 49: Data Table on Comparison by End-user

• 6.3 Hospitals - Market size and forecast 2022-2027
• Exhibit 50: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 51: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibit 53: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)

• 6.4 Ambulatory surgical centers (ASCs) - Market size and forecast 2022-2027 
• Exhibit 54: Chart on Ambulatory surgical centers (ASCs) - Market size and forecast 2022-2027 ($ million)
• Exhibit 55: Data Table on Ambulatory surgical centers (ASCs) - Market size and forecast 2022-2027 ($ million)
• Exhibit 56: Chart on Ambulatory surgical centers (ASCs) - Year-over-year growth 2022-2027 (%)
• Exhibit 57: Data Table on Ambulatory surgical centers (ASCs) - Year-over-year growth 2022-2027 (%)

• 6.5 Others - Market size and forecast 2022-2027
• Exhibit 58: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 59: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 60: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 61: Data Table on Others - Year-over-year growth 2022-2027 (%)

• 6.6 Market opportunity by End-user 
• Exhibit 62: Market opportunity by End-user ($ million)

7 Customer Landscape

• 7.1 Customer landscape overview 
• Exhibit 63: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

• 8.1 Geographic segmentation 
• Exhibit 64: Chart on Market share by geography 2022-2027 (%)
• Exhibit 65: Data Table on Market share by geography 2022-2027 (%)

• 8.2 Geographic comparison 
• Exhibit 66: Chart on Geographic comparison
• Exhibit 67: Data Table on Geographic comparison

• 8.3 North America - Market size and forecast 2022-2027
• Exhibit 68: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 71: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 8.4 Asia - Market size and forecast 2022-2027
• Exhibit 72: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 75: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 8.5 Europe - Market size and forecast 2022-2027
• Exhibit 76: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 79: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 8.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 80: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 83: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 8.7 US - Market size and forecast 2022-2027
• Exhibit 84: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 87: Data Table on US - Year-over-year growth 2022-2027 (%)

• 8.8 China - Market size and forecast 2022-2027
• Exhibit 88: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 91: Data Table on China - Year-over-year growth 2022-2027 (%)

• 8.9 Germany - Market size and forecast 2022-2027
• Exhibit 92: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 95: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 8.10 UK - Market size and forecast 2022-2027
• Exhibit 96: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 99: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 8.11 Canada - Market size and forecast 2022-2027
• Exhibit 100: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 102: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 103: Data Table on Canada - Year-over-year growth 2022-2027 (%)

• 8.12 Market opportunity by geography 
• Exhibit 104: Market opportunity by geography ($ million)

9 Drivers, Challenges, and Trends

• 9.1 Market drivers

• 9.2 Market challenges

• 9.3 Impact of drivers and challenges 
• Exhibit 105: Impact of drivers and challenges in 2022 and 2027

• 9.4 Market trends

10 Vendor Landscape

• 10.1 Overview

• 10.2 Vendor landscape 
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation

• 10.3 Landscape disruption 
• Exhibit 107: Overview on factors of disruption

• 10.4 Industry risks 
• Exhibit 108: Impact of key risks on business

11 Vendor Analysis

• 11.1 Vendors covered 
• Exhibit 109: Vendors covered

• 11.2 Market positioning of vendors 
• Exhibit 110: Matrix on vendor position and classification

• 11.3 Abbott Laboratories 
• Exhibit 111: Abbott Laboratories - Overview
• Exhibit 112: Abbott Laboratories - Business segments
• Exhibit 113: Abbott Laboratories - Key news
• Exhibit 114: Abbott Laboratories - Key offerings
• Exhibit 115: Abbott Laboratories - Segment focus

• 11.4 Agena Bioscience Inc. 
• Exhibit 116: Agena Bioscience Inc. - Overview
• Exhibit 117: Agena Bioscience Inc. - Product / Service
• Exhibit 118: Agena Bioscience Inc. - Key offerings

• 11.5 AXO Science 
• Exhibit 119: AXO Science - Overview
• Exhibit 120: AXO Science - Product / Service
• Exhibit 121: AXO Science - Key offerings

• 11.6 Becton Dickinson and Co. 
• Exhibit 122: Becton Dickinson and Co. - Overview
• Exhibit 123: Becton Dickinson and Co. - Business segments
• Exhibit 124: Becton Dickinson and Co. - Key news
• Exhibit 125: Becton Dickinson and Co. - Key offerings
• Exhibit 126: Becton Dickinson and Co. - Segment focus

• 11.7 Bio Rad Laboratories Inc. 
• Exhibit 127: Bio Rad Laboratories Inc. - Overview
• Exhibit 128: Bio Rad Laboratories Inc. - Business segments
• Exhibit 129: Bio Rad Laboratories Inc. - Key news
• Exhibit 130: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 131: Bio Rad Laboratories Inc. - Segment focus

• 11.8 Cardinal Health Inc. 
• Exhibit 132: Cardinal Health Inc. - Overview
• Exhibit 133: Cardinal Health Inc. - Business segments
• Exhibit 134: Cardinal Health Inc. - Key news
• Exhibit 135: Cardinal Health Inc. - Key offerings
• Exhibit 136: Cardinal Health Inc. - Segment focus

• 11.9 CSL Ltd. 
• Exhibit 137: CSL Ltd. - Overview
• Exhibit 138: CSL Ltd. - Business segments
• Exhibit 139: CSL Ltd. - Key news
• Exhibit 140: CSL Ltd. - Key offerings
• Exhibit 141: CSL Ltd. - Segment focus

• 11.10 F. Hoffmann La Roche Ltd. 
• Exhibit 142: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 143: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 144: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 145: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 146: F. Hoffmann La Roche Ltd. - Segment focus

• 11.11 Grifols SA 
• Exhibit 147: Grifols SA - Overview
• Exhibit 148: Grifols SA - Business segments
• Exhibit 149: Grifols SA - Key offerings
• Exhibit 150: Grifols SA - Segment focus

• 11.12 Haemonetics Corp. 
• Exhibit 151: Haemonetics Corp. - Overview
• Exhibit 152: Haemonetics Corp. - Business segments
• Exhibit 153: Haemonetics Corp. - Key offerings
• Exhibit 154: Haemonetics Corp. - Segment focus

• 11.13 Immucor Inc. 
• Exhibit 155: Immucor Inc. - Overview
• Exhibit 156: Immucor Inc. - Product / Service
• Exhibit 157: Immucor Inc. - Key offerings

• 11.14 Medtronic Plc 
• Exhibit 158: Medtronic Plc - Overview
• Exhibit 159: Medtronic Plc - Business segments
• Exhibit 160: Medtronic Plc - Key news
• Exhibit 161: Medtronic Plc - Key offerings
• Exhibit 162: Medtronic Plc - Segment focus

• 11.15 Nipro Medical Corp. 
• Exhibit 163: Nipro Medical Corp. - Overview
• Exhibit 164: Nipro Medical Corp. - Product / Service
• Exhibit 165: Nipro Medical Corp. - Key offerings

• 11.16 Rapid Labs Ltd. 
• Exhibit 166: Rapid Labs Ltd. - Overview
• Exhibit 167: Rapid Labs Ltd. - Product / Service
• Exhibit 168: Rapid Labs Ltd. - Key offerings

• 11.17 Terumo Corp. 
• Exhibit 169: Terumo Corp. - Overview
• Exhibit 170: Terumo Corp. - Business segments
• Exhibit 171: Terumo Corp. - Key news
• Exhibit 172: Terumo Corp. - Key offerings
• Exhibit 173: Terumo Corp. - Segment focus

12 Appendix

• 12.1 Scope of the report

• 12.2 Inclusions and exclusions checklist 
• Exhibit 174: Inclusions checklist
• Exhibit 175: Exclusions checklist

• 12.3 Currency conversion rates for US$ 
• Exhibit 176: Currency conversion rates for US$

• 12.4 Research methodology 
• Exhibit 177: Research methodology
• Exhibit 178: Validation techniques employed for market sizing
• Exhibit 179: Information sources

• 12.5 List of abbreviations 
• Exhibit 180: List of abbreviations

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio